The challenge of selecting adjuvant breast cancer chemotherapy for older patients

Oncology (Williston Park). 2010 Jun;24(7):621, 624.
No abstract available

Publication types

  • Comment

MeSH terms

  • Aged
  • Aged, 80 and over
  • Aging*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / genetics*
  • Breast Neoplasms / pathology
  • Chemotherapy, Adjuvant
  • Female
  • Humans
  • Life Expectancy
  • Neoplasm Staging
  • Receptor, ErbB-2 / drug effects*
  • Risk Factors
  • Women's Health

Substances

  • ERBB2 protein, human
  • Receptor, ErbB-2